In terms of private investments, 2020 was the year of the liquid biopsy.
Fortunately for medical device start-ups, it takes more than a pandemic to put venture capitalists off doing deals.
Investors swerve traditional medical devices in favour of artificial intelligence-enabled diagnostics.
In a truly extraordinary year, the top 10 venture rounds made up more than half of the total invested.
So far, 2017 has been a record-breaker in a number of ways – and none of them bode well for start-ups.